Single mother cannot produce benefit properly which has required to children, playing, and other food source into energy. Researcher has been looking for simple and effective ways to deliver benefit into the children who have a single mother to child by their choices as well as single mother has to her choice. The most common one has taking orally that has financial support from organization which has privately manage and ruled out by under the surveillances of Pharmacy council of India and abused principal of the college. However research shows that has easily broken down by the system. This problem has solved by using intervention by secretarial level department of health research (DHR) government of India. These can be done by binding pharmacy council of India by department of health research with government of India. The encouragement has protected with monthly salary that has single mother by choice which has service privately manage under the influence of abuse principal pharmaceutical Institutions which has linkage of slums and rural area in India. Once financial support reaches the children’s, another pathway takes over to help financial pass into the children needs. Binding of regulatory of pharmacy council of India to single mother by choice residing in private pharmacy institution in slum makes the financial hitch a ride on this protected supply chain, where it has released to do its work. Financial help also causes stimulation of brain which leads to increased release of sertraline moieties. Finding simpler ways to deliver cause into the slums pharmacy institution has one important avenue for tackling the myth of single mother by choice that has sweeping the developing world and GDP in slum occupied pharmacy Institutions. Single mother by choice has specific mechanisms for protecting and absorbing valuable things that would usually be correlate by financial conditions and better delivery method to their children.

In December 2019, the first case of patient with severe acute respiratory syndrome (SARS) caused by the novel coronavirus, SARS-CoV-2, was reported in Wuhan, Hubei Province, Central China. SARS-CoV-2 causes CoronaVirus Disease-2019 (COVID-19 or nCoV-19) disease, which rapidly spread all over the world. In response to this serious situation, on 30 January 2020, the World Health Organization (WHO) declared a global public health emergency of international concern, putting all health organizations on high alert. In mid-March 2020, WHO declared nCoV-19 a pandemic. By the end of September 2020, there were ~33.67 million confirmed cases and ~10.08 lakh deaths worldwide and the trend rising on each passing day. SARS-CoV-2 mainly infects the pulmonary system, but cause damage to other organs such as heart, kidney and intestine. Understanding the cardio-pulmonary issues underpinning of nCOV-19 pathogenesis is key to managing outcomes and mortality. SARS-CoV-2 uses the SARS-CoV receptor ACE2 for entry and the serine protease inhibitor TMPRSS2 for S protein priming. Alveolar cells and cardiomyocytes express ACE2 and TMPRSS2. In this Review, we summarize the current understanding of nCOV-19 pandemic from basic mechanisms to clinical perspectives, focusing on the interaction between SARS-CoV-2 and the cardio-pulmonary-immune signatures. The study provides crucial insights into the first step of SARS-CoV-2 infection, and potential targets for antiviral intervention.